Employers & Lawyers,
Working Together®

2026 Compliance Challenges:
New Templates

Locations in North America and Europe

A talented workforce
and a tradition of
excellence

Ogletree Deakins Honored as a 2025 Innovation Icon by BTI Consulting Group

 
Resources

Workplace compliance and training solutions
tailored to our clients

Events

CBD oil in flacons, green cannabis, jade mortar and pestle against wooden wall close-up

From Schedule I to III: What the DOJ’s Medical Marijuana Reclassification Means for Alabama and Multistate Employers

Birmingham, AL

The U.S. Department of Justice’s April 2026 order reclassifying certain marijuana products from Schedule I to Schedule III under the Controlled Substances Act marks a seismic shift in federal drug policy—and raises urgent questions for employers navigating workplace drug policies, disability accommodation requests under the ADA, and drug testing programs. The speaker will discuss the order’s key distinctions, including the divide between medical and non-medical use, the unsettled implications for DOT-regulated workforces, and the continued relevance of existing state law obligations. The speaker will also discuss the potential ADA-related claims and risks facing Alabama employers, particularly now that Alabama’s medical marijuana program is operational after years of delays following the law’s 2021 passage. Attendees will receive practical, business-focused guidance on how to audit their current drug policies and effectively position their organizations for this new landscape.

modern angular desk with workers, shot from above
Practice and Industry Groups

Representation across all industries and employment-related practice areas

Ogletree has experienced professionals who provide efficient, client-focused service in all areas of labor and employment law and across all industries.
See All

Let us know how we can help you navigate your particular workplace legal issues.